Immune-Mediated Inflammatory Diseases, Dyslipidemia, and Cardiovascular Risk: A Complex Interplay.

Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15-39, 1990-2021.

IL-6 and Cardiovascular Risk: A Narrative Review.

Association of circulating ketone bodies with cognitive performance and dementia in the Multi-Ethnic Study of Atherosclerosis (MESA).

A vision for the future: ASPC's new educational offerings for 2025.

Association of Lipoprotein(a) With Major Adverse Cardiovascular Events Across hs-CRP: A Systematic Review and Meta-Analysis.

A Step Forward for Long-Acting PCSK9 Inhibition: Improvements Without a Breakthrough.

Global burden of metabolic diseases, 1990-2021.

Worldwide prevalence of chagas cardiomyopathy-an analysis from the global burden of disease dataset.

Low-density lipoprotein-cholesterol and subclinical coronary atherosclerosis in a middle-aged asymptomatic U.S. population: The Miami Heart Study at Baptist Health South Florida.